TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-Amyloid oligomers in mice and monkeys

Lourenco, M. V., Clarke, J. R., Frozza, R. L., Bomfim, T. R., Forny-Germano, L., Batista, A. F., Sathler, L. B., Brito-Moreira, J., Amaral, O. B., Silva, C. A., Freitas-Correa, L., Espírito-Santo, S., Campello-Costa, P., Houzel, J.-C., Klein, W. L., Holscher, C., Carvalheira, J. B., Silva, A. M., Velloso, L. A. & Munoz, D. P. & 2 others, Ferreira, S. T. & De Felice, F. G., 3/12/2013, In: Cell Metabolism. 18, 6, p. 831-843 13 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Glucagon like peptide-1 receptor agonists as neuroprotective agents for ischemic stroke: a systematic scoping review

Maskery, M. P., Holscher, C., Jones, S. P., Price, C. I., Strain, W. D., Watkins, C. L., Werring, D. J. & Emsley, H. C. A., 1/01/2021, In: Journal of Cerebral Blood Flow and Metabolism. 41, 1, p. 14-30 17 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

The diabetes drug Liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease

McClean, P. L., Parthsarathy, V., Faivre, E. & Holscher, C., 27/04/2011, In: Journal of Neuroscience. 31, 17, p. 6587-6594 8 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer ‘s disease

McClean, P. L. & Holscher, C., 2013, In: Neuropharmacology. 76, Part A, p. 57-67 11 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease

McClean, P. L., Gault, V. A., Harriott, P. & Hölscher, C., 25/03/2010, In: European Journal of Pharmacology. 630, 1-3, p. 158-162 5 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1 mice

McClean, P. L., Jalewa, J. & Holscher, C., 15/10/2015, In: Behavioural Brain Research. 293, p. 96-106 11 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease

McClean, P. L. & Holscher, C., 11/2014, In: Neuropharmacology. 86, p. 241-258 18 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Effects of the glucagon-like polypeptide-1 analogue (Val8)GLP-1 on learning, progenitor cell proliferation and neurogenesis in the C57B/16 mouse brain

McGovern, S. F. J., Hunter, K. & Hölscher, C., 14/09/2012, In: Brain Research. 1473, p. 204-213 10 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Wide-ranging alterations in the brain fatty acid complement of subjects with late Alzheimer’s disease as detected by GC-MS

Nasaruddin, M. L., Holscher, C., Kehoe, P., Graham, S. F. & Green, B., 30/01/2016, In: American Journal of Translational Research. 8, 1, p. 154-165 12 p.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Pharmacological inhibition of CSF1R blocks microglial proliferation and prevents the progression of Alzheimer's-like pathology

Olmos-Alonso, A., Schetters, S. T., Sri, S., Askew, K., Vargas-Caballero, M., Holscher, C., Perry, V. H. & Gomez-Nicola, D., 08/2015, In: Glia. 63, Suppl. 1, p. E346-E347 2 p.

Research output: Contribution to Journal/Magazine › Meeting abstract › peer-review